Skip to main content
. 2010 Sep 6;18(4):e29–e39. doi: 10.1111/j.1365-2893.2010.01360.x

Figure 1.

Figure 1

 Identification of multidrug‐resistant (MDR) mutations. Clonal sequencing identified that eight patients who received sequential NA harboured MDR mutants with signature mutations resistant to both nucleoside (LAM/LdT/ETV) and nucleotide analogues (ADV). The NA treatment schedules are shown at the bottom of the figure. Treatment duration (month) is indicated in brackets. LAM, lamivudine; ADV, adefovir; ETV, entecavir; LdT, telbivudine; NA, nucleos(t)ide analogues.